Back to Browse Journals » International Journal of Nanomedicine » Volume 6

Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy

Authors Bizzarri AR, Santini S, Coppari E, Bucciantini M, Di Agostino S, Yamada T, Beattie CW, Cannistraro S

Published Date November 2011 Volume 2011:6 Pages 3011—3019

DOI http://dx.doi.org/10.2147/IJN.S26155

Published 24 November 2011

Anna Rita Bizzarri1, Simona Santini1, Emilia Coppari1, Monica Bucciantini2, Silvia Di Agostino3, Tohru Yamada4, Craig W Beattie4, Salvatore Cannistraro1
1
Biophysics and Nanoscience Centre, CNISM, Facoltà di Scienze, Università della Tuscia, Viterbo, 2Department of Biochemical Sciences, University of Florence, Florence, 3Molecular Oncogenesis Laboratory, Experimental Oncology Department, Regina Elena Cancer Institute, Rome, Italy; 4Department of Surgical Oncology, University of Illinois College of Medicine, Chicago, IL, USA

Abstract: p28 is a 28-amino acid peptide fragment of the cupredoxin azurin derived from Pseudomonas aeruginosa that preferentially penetrates cancerous cells and arrests their proliferation in vitro and in vivo. Its antitumor activity reportedly arises from post-translational stabilization of the tumor suppressor p53 normally downregulated by the binding of several ubiquitin ligases. This would require p28 to specifically bind to p53 to inhibit specific ligases from initiating proteosome-mediated degradation. In this study, atomic force spectroscopy, a nanotechnological approach, was used to investigate the interaction of p28 with full-length p53 and its isolated domains at the single molecule level. Analysis of the unbinding forces and the dissociation rate constant suggest that p28 forms a stable complex with the DNA-binding domain of p53, inhibiting the binding of ubiquitin ligases other than Mdm2 to reduce proteasomal degradation of p53.

Keywords: AFS, cancer physics, unbinding forces

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

SERS-based nanobiosensing for ultrasensitive detection of the p53 tumor suppressor

Domenici F, Bizzarri AR, Cannistraro S

International Journal of Nanomedicine 2011, 6:2033-2042

Published Date: 19 September 2011

Readers of this article also read:

Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior

Karavelidis V, Karavas E, Giliopoulos D, Papadimitriou S, Bikiaris D

International Journal of Nanomedicine 2011, 6:3021-3032

Published Date: 24 November 2011

Coupling technique of random amplified polymorphic DNA and nanoelectrochemical sensor for mapping pancreatic cancer genetic fingerprint

Liu Q, Liu A, Gao F, Weng S, Zhong G, Liu  J, Lin X, Lin J, Chen X

International Journal of Nanomedicine 2011, 6:2933-2939

Published Date: 21 November 2011

Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study

Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R

International Journal of Nanomedicine 2011, 6:2859-2864

Published Date: 11 November 2011

The changing face of dentistry: nanotechnology

Kanaparthy R, Kanaparthy A

International Journal of Nanomedicine 2011, 6:2799-2804

Published Date: 9 November 2011

Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells

Fekrazad R, Hakimiha N, Farokhi E, Rasaee MJ, Ardestani MS, Kalhori KA, Sheikholeslami F

International Journal of Nanomedicine 2011, 6:2749-2755

Published Date: 9 November 2011

New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell

Kashanian S, Hemati Azandaryani A, Derakhshandeh K

International Journal of Nanomedicine 2011, 6:2393-2401

Published Date: 1 November 2011

Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment

Ma Y, Zheng Y, Zeng X, Jiang L, Cheng H, Liu R, Huang L, Mei L

International Journal of Nanomedicine 2011, 6:2679-2688

Published Date: 1 November 2011

In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide

Mou YB, Hou YY, Chen BA, Hua ZC, Zhang Y, Xie H, Xia GH, Wang ZY, Huang XF, Han W, Ni YH, Hu QG

International Journal of Nanomedicine 2011, 6:2633-2640

Published Date: 28 October 2011

Novel formulation of a methotrexate derivative with a lipid nanoemulsion

Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhao RC

International Journal of Nanomedicine 2011, 6:2285-2295

Published Date: 12 October 2011